February 1, 2016 ChromaCon launches the Contichrom CUBE 100 FPLC systems
Press Release
The full press release can be downloaded as a pdf.
ChromaCon launches the Contichrom® CUBE 100 FPLC systems
Zurich, February 2016. ChromaCon launches the Contichrom® CUBE 100 system worldwide. A dedicated FPLC system for protein and oligonucleotide purification, the system provides high throughput capabilities. The Contichrom® CUBE 100 is a product extension of the Contichrom® CUBE 30 systems that was launched in early 2015. The new system has an almost three-fold higher maximum flow rate at 100 mL/min, allowing to process larger amounts of feed material. It employs the same user-friendly ChromIQ® software with all processes as the CUBE 30 systems. The CUBE 100 systems are particularly useful for intermediate-scale process development of continuous processes leading to scale-up using GMP twin-column systems manufactured by ChromaCon’s partner LEWA Process Technologies (Devens, MA, USA).
For more information on the Contichrom® CUBE 100 and ChromaCon please contact us directly or visit our website www.chromacon.com.
About ChromaCon
ChromaCon AG is a private Life Science Tool company located in Zürich, Switzerland, providing best-in-class process solutions to the biopharmaceutical industry. ChromaCon has developed and patented novel process principles, process control, equipment designs and operating software for batch, cyclic and continuous chromatography, providing significant CAPEX and OPEX cost savings and enabling scalable chromatographic solutions for large scale purification applications. The Contichrom® laboratory-scale equipment is co-marketed worldwide by ChromaCon and its partners. ChromaCon has provided global licenses for its process technologies to LEWA Process Technologies (Devens, MA, USA) for implementation into scale-up systems. ChromaCon also develops and markets affinity purification solutions for column and membrane chromatography applications and tools for site-specific protein conjugation.
ChromaCon Contact
To find out more about ChromaCon please contact us directly or visit our website.
Dr. Michael Bavand, CEO, info@chromacon.com, www.chromacon.com